Don't worry; we have the solutions.
For individuals unfamiliar with the process, clinical trials may raise numerous inquiries.

The Atlas model places a strong emphasis on making our procedures and trials as accessible and understandable as possible for our patients. We recognize that you might have questions about our processes, protocols, and the advantages of joining our trials. Therefore, we offer potential participants a variety of concise and detailed responses to frequently asked questions about clinical research. Our goal is to answer as many of these questions as we can, but should you not find the information you seek, please don’t hesitate to contact our dedicated support team, who are always prepared to help you.
Who may participate in clinical trials?
A participant in a clinical trial must meet the study’s eligibility requirements and live in the Greater Rochester region. Some research projects seek volunteers with diseases or ailments to study in clinical trials, whilst others want healthy subjects. All clinical studies have participation guidelines. The use of criteria for each unique study is an important tenet of medical research that aids in the production of dependable results.
- Age
- Gender
- Disease type and stage.
- Past treatment history
- Other medical conditions
Eligible volunteers can benefit most from well-designed and conducted clinical studies by:
- Take an active part in their medical treatment.
- Get access to novel research therapies before they are generally released.
- Contribute to medical research to help others.
Clinical trial hazards include:
- Therapy may have unfavorable, dangerous, or even deadly adverse effects.
- The individual may not benefit from the treatment.
- Compared to a non-protocol therapy, the protocol could involve more time and effort from them, such as visits to the research site, additional treatments, hospital stays, or complicated dose requirements.
Informed consent is a process designed to ensure that individuals fully understand the essential details of a clinical trial before choosing to participate. This process continues throughout the trial, providing participants with ongoing information. To assist someone in deciding whether to join the study, the doctors and nurses involved explain the study’s specifics. The research team then presents an informed consent form, which outlines important aspects such as the study’s purpose, duration, required procedures, and key contacts. The risks and potential benefits are also detailed in this document. The participant can then choose whether to sign the form. It’s important to note that informed consent is not a binding contract, and participants can withdraw from the trial at any time.
Individuals should have a thorough understanding of the clinical trial and should not hesitate to inquire about it with healthcare providers, including details on care, expectations, and expenses.
The participant may find the following questions useful when talking to the healthcare team. The informed consent document contains answers to some of these questions.
What is the aim of the research?
Who will participate in the research?
What is the reason researchers have faith in the potential effectiveness of the new treatment under evaluation? Has it undergone testing previously?
What types of examinations and therapies are included?
How do the risks, side effects, and benefits of the study stack up against those of my current treatment?
In what way could this experiment impact my day-to-day existence?
What is the estimated duration of the trial?
Is hospitalization necessary?
Who is responsible for covering the cost of the treatment?
Will I receive compensation for additional costs?
What kind of ongoing care is included in this research for the long term?
How can I determine if the treatment is effective? Am I going to receive the outcomes of the experiments?
Who will be responsible for my treatment?
Each clinical trial conducted in the United States requires authorization and oversight from an Institutional Review Board (IRB) to minimize risks and ensure the benefits outweigh any potential drawbacks. An IRB is a group of physicians, statisticians, community advocates, and others who guarantee the ethical conduct of a clinical trial and safeguard the rights of study participants. Every organization involved in biomedical research with human participants is required by federal law to have an Institutional Review Board (IRB) that must approve and monitor the research on a regular basis. Consider the following arrangements:
Create a plan and make a list of potential inquiries.
Request the presence of a friend or family member to provide support and listen to the answers to the questions.
Remember to bring a tape recorder to capture the conversation and listen to it again afterwards.
Yes. A person can withdraw from a Clinical trial at any point. Upon opting out of the trial, the participant must inform the research team and provide an explanation for discontinuing participation in the study.
A control serves as a benchmark for assessing experimental observations. In numerous medical studies, a set of patients receives an experimental medication or therapy, while another set receives either a standard treatment or a placebo for the same condition.
If you would like to learn more about clinical trials, please contact us or read our FAQ.
